20 Apr, 2016

AACR 2016 Research Shows Circulogene Liquid Biopsy Excels at Real-Time Monitoring of Cancer Mutations

AACR 2016 Research Shows Circulogene Liquid Biopsy Excels at Real-Time Monitoring of Cancer Mutations Interlab comparison demonstrates Circulogene’s blood-drop-volume liquid biopsy assay is fastest, most accurate process to date for tracking and treating cancer BIRMINGHAM, Ala., – [...]

2 Mar, 2016

First International Orders for Cell-Free DNA Liquid Biopsy Testing Accepted

Circulogene Accepts First International Orders for Cell-Free DNA Liquid Biopsy Testing Single-blood-drop, high-yield DNA testing drives international demand for Circulogene’s fast, accurate, cancer monitoring and treatment products BIRMINGHAM, Ala., March 2, 2016 (BUSINESS WIRE) – Circulogene Theranostics, [...]

10 Feb, 2016

Circulogene Theranostics, UAB Comprehensive Cancer Center Join Forces, Announce Research Agreement

Circulogene Theranostics, UAB Comprehensive Cancer Center Announce Research Agreement   BIRMINGHAM, Ala., February 10, 2016 (BUSINESS WIRE) ­­­– Circulogene Theranostics, the only biotechnology company able to enrich circulating cell-free DNA (cfDNA) from a single blood drop for patient-specific [...]

5 Jan, 2016

Circulogene Theranostics Names James A. Posey III, M.D., as Chief Medical Advisor

Circulogene Theranostics Names James A. Posey III, M.D., as Chief Medical Advisor BIRMINGHAM, Ala., January 5, 2016 (BUSINESS WIRE)--Circulogene Theranostics the only biotechnology company able to enrich circulating cell-free DNA (cfDNA) from a single blood drop [...]

10 Nov, 2015

Circulogene Launches Liquid Biopsy Product Into Market

Proprietary Finger-Stick Cancer Monitoring Technology Launches Circulogene Theranostics into Liquid Biopsy Market Breakthrough, cell-free DNA testing method enables fast, accurate, personalized cancer monitoring and treatment guidance with a single blood drop BIRMINGHAM, Ala., November 10, [...]